Impairment testing - Narrative (Details) € in Millions |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2025
EUR (€)
product
|
Dec. 31, 2024
EUR (€)
|
|
| Disclosure of impairment loss and reversal of impairment loss [line items] | ||
| Number of products | product | 2 | |
| Impairment loss (reversal of impairment loss) recognised in profit or loss | € | € 0.0 | € 0.0 |
| DUKORAL® | ||
| Disclosure of impairment loss and reversal of impairment loss [line items] | ||
| Value in use to equal carrying amount, revenue increase (decrease), percentage | (1.50%) | |
| IXIARO / IXCHIQ | ||
| Disclosure of impairment loss and reversal of impairment loss [line items] | ||
| Value in use to equal carrying amount, revenue increase (decrease), percentage | (13.00%) | |